Copyright Reports & Markets. All rights reserved.

Global Dutasteride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Dutasteride API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Dutasteride API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Dutasteride Tablets
    • 1.4.3 Dutasteride Capsules
    • 1.4.4 Others
  • 1.5 Global Dutasteride API Market Size & Forecast
    • 1.5.1 Global Dutasteride API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Dutasteride API Sales Quantity (2020-2031)
    • 1.5.3 Global Dutasteride API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Dutasteride API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Gonane Pharma
    • 2.2.1 Gonane Pharma Details
    • 2.2.2 Gonane Pharma Major Business
    • 2.2.3 Gonane Pharma Dutasteride API Product and Services
    • 2.2.4 Gonane Pharma Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Gonane Pharma Recent Developments/Updates
  • 2.3 Sterling Spa
    • 2.3.1 Sterling Spa Details
    • 2.3.2 Sterling Spa Major Business
    • 2.3.3 Sterling Spa Dutasteride API Product and Services
    • 2.3.4 Sterling Spa Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sterling Spa Recent Developments/Updates
  • 2.4 Stermone Chemicals
    • 2.4.1 Stermone Chemicals Details
    • 2.4.2 Stermone Chemicals Major Business
    • 2.4.3 Stermone Chemicals Dutasteride API Product and Services
    • 2.4.4 Stermone Chemicals Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Stermone Chemicals Recent Developments/Updates
  • 2.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.
    • 2.5.1 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Details
    • 2.5.2 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Major Business
    • 2.5.3 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product and Services
    • 2.5.4 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.6 Gador SA
    • 2.6.1 Gador SA Details
    • 2.6.2 Gador SA Major Business
    • 2.6.3 Gador SA Dutasteride API Product and Services
    • 2.6.4 Gador SA Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Gador SA Recent Developments/Updates
  • 2.7 Cipla
    • 2.7.1 Cipla Details
    • 2.7.2 Cipla Major Business
    • 2.7.3 Cipla Dutasteride API Product and Services
    • 2.7.4 Cipla Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cipla Recent Developments/Updates
  • 2.8 Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
    • 2.8.1 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Details
    • 2.8.2 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Major Business
    • 2.8.3 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product and Services
    • 2.8.4 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.9 Aspen Biopharma Labs
    • 2.9.1 Aspen Biopharma Labs Details
    • 2.9.2 Aspen Biopharma Labs Major Business
    • 2.9.3 Aspen Biopharma Labs Dutasteride API Product and Services
    • 2.9.4 Aspen Biopharma Labs Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Aspen Biopharma Labs Recent Developments/Updates
  • 2.10 Chongqing Huapont Pharmaceutical
    • 2.10.1 Chongqing Huapont Pharmaceutical Details
    • 2.10.2 Chongqing Huapont Pharmaceutical Major Business
    • 2.10.3 Chongqing Huapont Pharmaceutical Dutasteride API Product and Services
    • 2.10.4 Chongqing Huapont Pharmaceutical Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
  • 2.11 Swati Spentose Pvt.Ltd.
    • 2.11.1 Swati Spentose Pvt.Ltd. Details
    • 2.11.2 Swati Spentose Pvt.Ltd. Major Business
    • 2.11.3 Swati Spentose Pvt.Ltd. Dutasteride API Product and Services
    • 2.11.4 Swati Spentose Pvt.Ltd. Dutasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Swati Spentose Pvt.Ltd. Recent Developments/Updates

3 Competitive Environment: Dutasteride API by Manufacturer

  • 3.1 Global Dutasteride API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Dutasteride API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Dutasteride API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Dutasteride API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Dutasteride API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Dutasteride API Manufacturer Market Share in 2024
  • 3.5 Dutasteride API Market: Overall Company Footprint Analysis
    • 3.5.1 Dutasteride API Market: Region Footprint
    • 3.5.2 Dutasteride API Market: Company Product Type Footprint
    • 3.5.3 Dutasteride API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Dutasteride API Market Size by Region
    • 4.1.1 Global Dutasteride API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Dutasteride API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Dutasteride API Average Price by Region (2020-2031)
  • 4.2 North America Dutasteride API Consumption Value (2020-2031)
  • 4.3 Europe Dutasteride API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Dutasteride API Consumption Value (2020-2031)
  • 4.5 South America Dutasteride API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Dutasteride API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Dutasteride API Sales Quantity by Type (2020-2031)
  • 5.2 Global Dutasteride API Consumption Value by Type (2020-2031)
  • 5.3 Global Dutasteride API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Dutasteride API Sales Quantity by Application (2020-2031)
  • 6.2 Global Dutasteride API Consumption Value by Application (2020-2031)
  • 6.3 Global Dutasteride API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Dutasteride API Sales Quantity by Type (2020-2031)
  • 7.2 North America Dutasteride API Sales Quantity by Application (2020-2031)
  • 7.3 North America Dutasteride API Market Size by Country
    • 7.3.1 North America Dutasteride API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Dutasteride API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Dutasteride API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Dutasteride API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Dutasteride API Market Size by Country
    • 8.3.1 Europe Dutasteride API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Dutasteride API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Dutasteride API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Dutasteride API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Dutasteride API Market Size by Region
    • 9.3.1 Asia-Pacific Dutasteride API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Dutasteride API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Dutasteride API Sales Quantity by Type (2020-2031)
  • 10.2 South America Dutasteride API Sales Quantity by Application (2020-2031)
  • 10.3 South America Dutasteride API Market Size by Country
    • 10.3.1 South America Dutasteride API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Dutasteride API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Dutasteride API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Dutasteride API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Dutasteride API Market Size by Country
    • 11.3.1 Middle East & Africa Dutasteride API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Dutasteride API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Dutasteride API Market Drivers
  • 12.2 Dutasteride API Market Restraints
  • 12.3 Dutasteride API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Dutasteride API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Dutasteride API
  • 13.3 Dutasteride API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Dutasteride API Typical Distributors
  • 14.3 Dutasteride API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dutasteride API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
    This report is a detailed and comprehensive analysis for global Dutasteride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dutasteride API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dutasteride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dutasteride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dutasteride API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dutasteride API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dutasteride API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Gonane Pharma, Sterling Spa, Stermone Chemicals, Hubei Gedian Humanwell Pharmaceutical Co.,Ltd., Gador SA, Cipla, Zhejiang Xianju Junye Pharmaceutical Co., Ltd., Aspen Biopharma Labs, Chongqing Huapont Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Dutasteride API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥98%
    Purity<98%
    Market segment by Application
    Dutasteride Tablets
    Dutasteride Capsules
    Others
    Major players covered
    Dr. Reddy’s Laboratories Ltd.
    Gonane Pharma
    Sterling Spa
    Stermone Chemicals
    Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.
    Gador SA
    Cipla
    Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
    Aspen Biopharma Labs
    Chongqing Huapont Pharmaceutical
    Swati Spentose Pvt.Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Dutasteride API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Dutasteride API, with price, sales quantity, revenue, and global market share of Dutasteride API from 2020 to 2025.
    Chapter 3, the Dutasteride API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Dutasteride API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dutasteride API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Dutasteride API.
    Chapter 14 and 15, to describe Dutasteride API sales channel, distributors, customers, research findings and conclusion.

    Buy now